Cibinetide: The Anti-Inflammatory Peptide for Tissue Repair
In the complex landscape of biological research, identifying molecules that can mitigate inflammation and promote tissue repair is a cornerstone of developing effective therapies. Cibinetide, also known as ARA-290, stands out as a particularly promising synthetic peptide in this regard. As a reputable peptide manufacturer and supplier, we are committed to providing the scientific community with access to this advanced compound, empowering groundbreaking research in inflammation and tissue regeneration. If you are looking to buy Cibinetide, our comprehensive offerings are designed to meet your research demands.
Cibinetide is a linear, nonhematopoietic peptide that is a derivative of erythropoietin (EPO). Its unique structure allows it to mimic the helix B surface domain of EPO, but crucially, it targets the non-hematopoietic EPO receptor (EPOR) in conjunction with the cytokine receptor subunit CD131. This specific interaction, often termed the innate repair receptor (IRR), is upregulated following tissue injury. Activation of the IRR by Cibinetide initiates a localized anti-inflammatory response, inhibits death signals, and prevents excessive tissue damage. This makes it an exceptional tool for studying and potentially treating a range of inflammatory conditions.
The anti-inflammatory effects of Cibinetide are profound. It has been shown to reduce the expression of pro-inflammatory cytokines such as TNF-α and IL-6, while simultaneously inhibiting the activation of key inflammatory pathways like NF-κB. This makes it highly relevant for research into chronic inflammatory diseases, including conditions like diabetic neuropathy, autoimmune disorders, and inflammatory conditions affecting organs such as the kidneys and lungs. For researchers seeking a high-quality ARA-290 peptide manufacturer, our facility in China offers superior products with guaranteed purity.
Beyond its anti-inflammatory action, Cibinetide also plays a significant role in tissue repair and protection. By inhibiting apoptosis and mitigating oxidative stress, it safeguards cells and promotes recovery, particularly in scenarios of hypoxia or injury. This dual action – combating inflammation and fostering repair – makes Cibinetide a valuable subject for research aiming to develop treatments for a variety of degenerative and injury-related conditions. Professionals looking to secure a reliable Cibinetide supplier will find our services efficient and our product quality exceptional.
When considering the purchase of ARA-290, it is essential to source from a reputable provider. Our company ensures that every batch of Cibinetide meets rigorous purity standards, making it suitable for advanced scientific applications. We understand the importance of reliable supply chains for ongoing research projects and are dedicated to being a steadfast partner. Explore the potential of this remarkable peptide; contact us to learn more about obtaining high-purity Cibinetide and discuss your research requirements with our expert team.
Perspectives & Insights
Quantum Pioneer 24
“Cibinetide is a linear, nonhematopoietic peptide that is a derivative of erythropoietin (EPO).”
Bio Explorer X
“Its unique structure allows it to mimic the helix B surface domain of EPO, but crucially, it targets the non-hematopoietic EPO receptor (EPOR) in conjunction with the cytokine receptor subunit CD131.”
Nano Catalyst AI
“This specific interaction, often termed the innate repair receptor (IRR), is upregulated following tissue injury.”